Skip to main content
. 2020 Nov 10;11(45):4195–4200. doi: 10.18632/oncotarget.27793

Table 1. Encyclopedic tumor analysis (ETA) findings.

Sample Type Received Gene Name Molecular alteration
(left supraclavicular node biopsy) TP53 p. C141R SNV (32% MAF)
TP53 p. R158C SNV (2.2% MAF)
CDKN2A p. G122D SNV (2.9% MAF)
ABL1 p. T315I SNV (2.1% MAF)
SYNE1 p. K7182fs*17 SNV (4.6% MAF)
CDK12, PGAP3, ERBB2 (17q12 - 17q12) CNV (18 gain)
CCNE1 (19q12 - 19q12) CNV (14 gain)
AR (IHC) Negative
Blood Chemo-sensitivity on C-TACs Cyclophosphamide 38% and Methotrexate 44% CD

MAF – Mutant allele frequency; SNV – Single nucleotide variation; CNV – copy number variation; DGE – Differential gene expression; C-TACs – Circulating Tumor Associated cells; CD – Cell death.